Search by Drug Name or NDC

NDC 00955-1022-08 Docetaxel 160 mg/8mL Details

Docetaxel 160 mg/8mL

Docetaxel is a INTRAVENOUS INJECTION, SOLUTION, CONCENTRATE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Winthrop U.S, a business of sanofi-aventis U.S. LLC. The primary component is DOCETAXEL.

MedlinePlus Drug Summary

Docetaxel injection is used alone or in combination with other medications to treat certain types of breast, lung, prostate, stomach, and head and neck cancers. Docetaxel injection is in a class of medications called taxanes. It works by stopping the growth and spread of cancer cells.

Related Packages: 00955-1022-08
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Docetaxel Injection

Product Information

NDC	00955-1022
Product ID	0955-1022_0beea4d6-76e2-c1d8-e063-6394a90ace94
Associated GPIs	21500005001317
GCN Sequence Number	067109
GCN Sequence Number Description	docetaxel VIAL 160 MG/8ML INTRAVEN
HIC3	V1F
HIC3 Description	ANTINEOPLASTICS,MISCELLANEOUS
GCN	29591
HICL Sequence Number	010280
HICL Sequence Number Description	DOCETAXEL
Brand/Generic	Generic
Proprietary Name	Docetaxel
Proprietary Name Suffix	n/a
Non-Proprietary Name	Docetaxel
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	INJECTION, SOLUTION, CONCENTRATE
Route	INTRAVENOUS
Active Ingredient Strength	160
Active Ingredient Units	mg/8mL
Substance Name	DOCETAXEL
Labeler Name	Winthrop U.S, a business of sanofi-aventis U.S. LLC
Pharmaceutical Class	Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]
DEA Schedule	n/a
Marketing Category	NDA AUTHORIZED GENERIC
Application Number	NDA020449
Listing Certified Through	2024-12-31

Package

NDC 00955-1022-08 (00955102208)

Pricing Information	N/A
NDC Package Code	0955-1022-08
Billing NDC	00955102208
Package	1 VIAL, GLASS in 1 CARTON (0955-1022-08) / 8 mL in 1 VIAL, GLASS
Marketing Start Date	2016-10-23
NDC Exclude Flag	N